MX2010006926A - 4-imidazolidinonas como inhibidores del canal de potasio kv1.5. - Google Patents

4-imidazolidinonas como inhibidores del canal de potasio kv1.5.

Info

Publication number
MX2010006926A
MX2010006926A MX2010006926A MX2010006926A MX2010006926A MX 2010006926 A MX2010006926 A MX 2010006926A MX 2010006926 A MX2010006926 A MX 2010006926A MX 2010006926 A MX2010006926 A MX 2010006926A MX 2010006926 A MX2010006926 A MX 2010006926A
Authority
MX
Mexico
Prior art keywords
imidazolidinones
potassium channel
channel inhibitors
present teachings
selective
Prior art date
Application number
MX2010006926A
Other languages
English (en)
Spanish (es)
Inventor
Shengde Wu
Benjamin E Blass
John M Janusz
James M Ii Ridgeway
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of MX2010006926A publication Critical patent/MX2010006926A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2010006926A 2007-12-19 2008-12-18 4-imidazolidinonas como inhibidores del canal de potasio kv1.5. MX2010006926A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1493707P 2007-12-19 2007-12-19
PCT/US2008/087459 WO2009079630A1 (fr) 2007-12-19 2008-12-18 4-imidazolidinones comme inhibiteurs du canal potassique kv1.5

Publications (1)

Publication Number Publication Date
MX2010006926A true MX2010006926A (es) 2010-08-02

Family

ID=40379648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006926A MX2010006926A (es) 2007-12-19 2008-12-18 4-imidazolidinonas como inhibidores del canal de potasio kv1.5.

Country Status (8)

Country Link
EP (1) EP2234983A1 (fr)
JP (1) JP2011507887A (fr)
AU (1) AU2008338374A1 (fr)
BR (1) BRPI0821394A2 (fr)
CA (1) CA2709187A1 (fr)
MX (1) MX2010006926A (fr)
WO (1) WO2009079630A1 (fr)
ZA (1) ZA201005086B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO3175985T3 (fr) 2011-07-01 2018-04-28
JP2015504923A (ja) 2012-01-27 2015-02-16 ギリアード サイエンシーズ， インコーポレイテッド 後期ナトリウムイオンチャネル遮断剤およびカリウムイオンチャネル遮断剤を使用する併用療法
WO2014134419A1 (fr) 2013-03-01 2014-09-04 Gilead Sciences, Inc. Utilisation de bloqueurs ikach pour le traitement de maladies cardiaques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125533A (en) * 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
PE20080207A1 (es) * 2006-06-20 2008-05-08 Wyeth Corp DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5

Also Published As

Publication number Publication date
EP2234983A1 (fr) 2010-10-06
WO2009079630A1 (fr) 2009-06-25
ZA201005086B (en) 2011-03-30
AU2008338374A1 (en) 2009-06-25
BRPI0821394A2 (pt) 2015-06-16
CA2709187A1 (fr) 2009-06-25
JP2011507887A (ja) 2011-03-10

Similar Documents

Publication Publication Date Title
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
IN2012DN03883A (fr)
TW200640924A (en) VEGF-R2 inhibitors and methods
JO3181B1 (ar) مشتقات كمحول ثاني الكيل البايردينيل - أحادي الفينيل كأنزيم ثنائي استرات الفوسفود
MX2010006154A (es) Tratamiento del cancer con combinaciones de inhibidores de la topoisomerasa e inhibidores de la poli-adp-ribosa-polimerasa.
MX2010004109A (es) 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
MY153915A (en) Organic compounds
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
TW200740803A (en) Heterocyclic derivatives as modulators of ion channels
MX2012004780A (es) Inhibidores de akt.
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
AU2009319796A8 (en) Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers
IL190730A0 (en) Potassium channel inhibitors
TW200634023A (en) Amide prodrug of gemcitabine, compositions and use thereof
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MY161461A (en) Akt and p70 s6 kinase inhibitors
IL205696A0 (en) Heterocyclic derivatives, compositions comprising the same and uses thereof
HK1133642A1 (en) Azaadamantane ester and carbamate derivatives and methods of use thereof
SG158091A1 (en) Imidazoazepinone compounds
IN2015DN03331A (fr)
MX2008001541A (es) Metodos para la preparacion de inhibidores de polimerasa del vhc.
MX2010006926A (es) 4-imidazolidinonas como inhibidores del canal de potasio kv1.5.
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal